Cover Image
市場調查報告書

非侵入性產前診斷(NIPT)市場(BambniTest、Harmony、informaSeq、MaterniT21 PLUS、NIFTY、Panorama、PrenaTest、verifi、VisibiliT) - 全球產業分析、規模、佔有率、成長、趨勢,及未來預測

Non-invasive Prenatal Testing (NIPT) Market (BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verifi, VisibiliT and Others) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 - 2022

出版商 Transparency Market Research 商品編碼 320980
出版日期 內容資訊 英文 112 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
非侵入性產前診斷(NIPT)市場(BambniTest、Harmony、informaSeq、MaterniT21 PLUS、NIFTY、Panorama、PrenaTest、verifi、VisibiliT) - 全球產業分析、規模、佔有率、成長、趨勢,及未來預測 Non-invasive Prenatal Testing (NIPT) Market (BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verifi, VisibiliT and Others) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast 2014 - 2022
出版日期: 2015年05月21日 內容資訊: 英文 112 Pages
簡介

非侵入性產前診斷是用於對唐氏症等胎兒染色體非整倍體風險高的孕婦篩檢。到最近,使用了羊水穿刺和絨毛切片檢查,母體血清篩檢等技術。可是由於非侵入性的產前診斷登場,解除了準確度和流產風險等傳統檢驗方法的問題點。

本報告提供全球非侵入性產前診斷市場相關的總括性調查、市場規模和今後的預測、競爭趨勢、主要加入企業簡介等彙整資料。

第1章 序論

第2章 摘要整理

第3章 全球非侵入性產前診斷(NIPT)市場概要

  • 簡介
  • 染色體非整倍體與其發病率
  • NIPT的技術性方法
  • 專利環境
  • 促進要素
    • 唐氏症的發病率高
    • 全球性晚婚化
    • 早期的非侵入性胎兒檢驗的需求擴大
  • 阻礙要素
    • 法律規章的指南和倫理的問題
    • NIPT的限制
    • 其他的檢驗方法的利用可能性
  • 市場機會
  • 波特五力分析
  • 市場魅力度分析
  • 競爭環境

第4章 全球非侵入性產前診斷市場收益

  • 概要
  • BambniTest
  • Harmony Prenatal Test
  • informaSeq Prenatal Test
  • MaterniT21 PLUS
  • NIFTY(非侵入性胎兒三染色體檢驗)
  • Panorama Test
  • PrenaTest
  • verifi
  • VisibiliT Test
  • 其他

第5章 各地區市場收益

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第6章 建議

  • 關注提高準確度縮短檢驗產生結果時間,降低價格的技術改良
  • 南美,構築亞太地區各國的診斷服務供應商的合作關係
  • 合併、收購

第7章 企業簡介

  • Ariosa Diagnostics, Inc.
  • Berry Genomics Co., Ltd
  • BGI Diagnostics
  • Illumina, Inc.
  • Laboratory Corporation of America Holdings (LabCorp)
  • LifeCodexx AG
  • Natera, Inc.
  • Sequenom, Inc.

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

Non-invasive prenatal testing (NIPT) is used for screening pregnant women at high risk of developing fetal chromosomal aneuploidies such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), Patau syndrome (trisomy 13), and Turner syndrome (monosomy X), and also for fetal sex determination. Until recently, amniocentesis, chorionic villus sampling (CVS), maternal serum screening and nuchal translucency (NT) scan were the primary diagnostic and screening methods for chromosomal abnormalities. Advent of non-invasive prenatal test is poised to eliminate disadvantages associated with these methods, such as low rate of accuracy with maternal serum screening and NT scan, and risk of miscarriage with invasive amniocentesis and CVS procedures. This report on non-invasive prenatal testing market studies the current market scenario and future potential for non-invasive prenatal tests globally. The major non-invasive prenatal tests studied in this report are BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verifi, VisibiliT and others (IONA, NACE, etc.). These tests have been extensively analyzed on the basis of factors such as the technology used, cost to patients, reimbursement coverage, accuracy and geographical reach (availability across various countries). The historical market size and forecast for each of these tests in terms of revenue (USD Million) and volume (Number of tests performed) have been given in the report for the period 2012 to 2022. In addition, the compounded annual growth rate (CAGR) of the overall non-invasive prenatal test market and the above tests has also been provided in the report for the forecast period 2014 to 2022, considering 2012 and 2013 as the base years. The report on non-invasive prenatal testing market also provides comparative analysis of major tests for the years 2013 and 2022.

In this research study, the global market for non-invasive prenatal testing has been geographically segmented into four regions, namely, North America, Europe, Asia-Pacific and Rest of the World (RoW). The non-invasive prenatal testing market size and forecast in terms of revenue (USD Million) and volume (Number of Tests Performed) for each region has been provided for the period 2012 to 2022 along with the CAGR for the forecast period 2014 to 2022. The non-invasive prenatal testing market study also includes qualitative analysis of the competitive scenario in these regions such as major collaboration and partnership, entry of new entrants, new product launch and other macro economic factors. The market overview section of the report on non-invasive prenatal testing market comprises qualitative analysis of the overall non-invasive prenatal testing market considering the factors determining the market dynamics such as drivers, restraints and opportunities along with the Porter's five force analysis and market attractiveness analysis. The market overview chapter also provides information such as major chromosomal aneuploidies (Down syndrome, Edwards syndrome, Patau syndrome and monosomy X, and their incidence rate, technological approach for NIPT and major patents issued to players operating in the market and other companies and academic research institutions.

The report also includes a section on the competitive landscape of the market, wherein the market share analysis of leading players in the global non-invasive prenatal testing market, in terms of percentage share in 2013 has been discussed. A list of recommendations has also been included for new entrants as well as existing market players to help them establish a strong presence in the non-invasive prenatal testing market and accentuate market shares. The report concludes with the profiles of major players in the NIPT market such as Sequenom, Inc., Ariosa Diagnostics, Natera, Inc., Illumina, Inc. (Verinata Health, Inc.), BGI Diagnostics, LifeCodexx AG, Laboratory Corporation of America Holdings (LabCorp) and Berry Genomics. Each company profile comprises information such as company overview, financial overview, product portfolio, business strategies and recent developments.

The global non-invasive prenatal testing market is segmented as follows:

Global Non-Invasive Prenatal Testing Market, by Test

  • BambniTest
  • Harmony
  • informaSeq
  • MaterniT21 PLUS
  • NIFTY
  • Panorama
  • PrenaTest
  • verifi
  • VisibiliT
  • Others

Global Non-Invasive Prenatal Testing Market, by Geography

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 Preface

  • 1.1 Report Description
  • 1.2 Market Segmentation
  • 1.3 Research Methodology
    • 1.3.1 Assumptions
    • 1.3.2 Sources
      • 1.3.2.1 Secondary Research
      • 1.3.2.2 Primary Research
    • 1.3.3 Models

Chapter 2 Executive Summary

  • 2.1 Market Snapshot: Global Non-Invasive Prenatal Testing (NIPT) Market (2013 & 2022)
  • 2.2 Global Non-Invasive Prenatal Testing Market, by Test, 2013 (USD Million)
  • 2.3 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2013 & 2022 (Value %)
  • 2.4 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Volume, by Geography, 2013 & 2022 (Volume %)

Chapter 3 Global Non-Invasive Prenatal Testing Market Overview

  • 3.1 Introduction
  • 3.2 Major Chromosomal Aneuploidies and their Incidence Rate
    • 3.2.1 Down Syndrome
    • 3.2.2 Edwards Syndrome
    • 3.2.3 Patau Syndrome
    • 3.2.4 Turner Syndrome
    • 3.2.5 Klinefelter Syndrome
    • 3.2.6 Jacobs Syndrome
    • 3.2.7 Triple X Syndrome
  • 3.3 Technological Approach for NIPT
  • 3.4 Patent Landscape
    • 3.4.1 Major Patents issued to Sequenom, Inc.
    • 3.4.2 Major Patents issued to Ariosa Diagnostics, Inc.
    • 3.4.3 Major Patents issued to Natera, Inc.
    • 3.4.4 Major Patents issued to Verinata Health, Inc. (Illumina, Inc.)
    • 3.4.5 Major Patents issued to Cellscape Corporation
    • 3.4.6 Others
  • 3.5 Market Drivers
    • 3.5.1 High incidence rate of babies born with Down syndrome
    • 3.5.2 Globally rising average maternal age
    • 3.5.3 Increasing demand for early and non-invasive fetal testing procedures
  • 3.6 Market Restraints
    • 3.6.1 Regulatory guidelines and ethical hurdles
    • 3.6.2 Limitations of NIPT
    • 3.6.3 Availability of other screening and testing methods
  • 3.7 Market Opportunities
    • 3.7.1 Capitalizing on the potential presented by the emerging markets of Asia
  • 3.8 Porter's Five Force Analysis: Global Non-Invasive Prenatal testing Market
    • 3.8.1 Bargaining power of suppliers
    • 3.8.2 Bargaining power of buyers
    • 3.8.3 Threat of substitutes
    • 3.8.4 Threat of new entrants
    • 3.8.5 Competitive rivalry
  • 3.9 Market Attractiveness Analysis: Global Non-Invasive Prenatal Testing Market, by Geography
    • 3.9.1 Market Attractive Analysis: Global Non-Invasive Prenatal Testing Market, by Geography
  • 3.10 Competitive Landscape
    • 3.10.1 Market Share Analysis, by Key Players, 2013 (%)
    • 3.10.2 Non-Invasive Prenatal Testing: Market Share, by Key Players, 2013(%)

Chapter 4 Global Non-Invasive Prenatal Testing Market Revenue (USD Million) and Volume (Number of Tests Performed), by Test

  • 4.1 Overview
    • 4.1.1 Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2012 - 2022 (USD Million)
    • 4.1.2 Global Non-Invasive Prenatal Testing Market Volume, by Test, 2012 - 2022 (Number of Tests Performed)
    • 4.1.3 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2013 & 2022 (Value %)
    • 4.1.4 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Volume, by Test, 2013 & 2022 (Volume %)
  • 4.2 BambniTest
    • 4.2.1 Global BambniTest Test Market Revenue, 2012 - 2022 (USD Million)
    • 4.2.2 Global BambniTest Test Market Volume, 2012 - 2022 (Number of Tests Performed)
  • 4.3 Harmony Prenatal Test
    • 4.3.1 Global Harmony Test Market Revenue, 2012 - 2022 (USD Million)
    • 4.3.2 Global Harmony Test Market Volume, 2012 - 2022 (Number of Tests Performed)
  • 4.4 informaSeq Prenatal Test
    • 4.4.1 Global informaSeq Test Market Revenue, 2014 - 2022 (USD Million)
    • 4.4.2 Global informaSeq Test Market Volume, 2014 - 2022 (Number of Tests Performed)
  • 4.5 MaterniT21 PLUS
    • 4.5.1 Global MaterniT21 PLUS Test Market Revenue, 2012 - 2022 (USD Million)
    • 4.5.2 Global MaterniT21 PLUS Test Market Volume, 2012 - 2022 (Number of Tests Performed)
  • 4.6 Non-invasive Fetal Trisomy (NIFTY) Test
    • 4.6.1 Global NIFTY Test Market Revenue, 2012 - 2022 (USD Million)
    • 4.6.2 Global NIFTY Test Market Volume, 2012 - 2022 (Number of Tests Performed)
  • 4.7 Panorama Test
    • 4.7.1 Global Panorama Test Market Revenue, 2012 - 2022 (USD Million)
    • 4.7.2 Global Panorama Test Market Volume, 2012 - 2022 (Number of Tests Performed)
  • 4.8 PrenaTest
    • 4.8.1 Global PrenaTest Test Market Revenue, 2012 - 2022 (USD Million)
    • 4.8.2 Global PrenaTest Test Market Volume, 2012 - 2022 (Number of Tests Performed)
  • 4.9 verifi
    • 4.9.1 Global verifi Test Market Revenue, 2012 - 2022 (USD Million)
    • 4.9.2 Global verifi Test Market Volume, 2012 - 2022 (Number of Tests Performed)
  • 4.10 VisibiliT Test
    • 4.10.1 Global VisibiliT Test Market Revenue, 2014 - 2022 (USD Million)
    • 4.10.2 Global VisibiliT Test Market Volume, 2014 - 2022 (Number of Tests Performed)
  • 4.11 Others
    • 4.11.1 Global Other Tests Market Revenue, 2014 - 2022 (USD Million)
    • 4.11.2 Global Other Tests Market Volume, 2014 - 2022 (Number of Tests Performed)

Chapter 5 Global Non-Invasive Prenatal Testing Market Revenue (USD Million) and Volume (Number of Tests Performed), by Geography

  • 5.1 Overview
    • 5.1.1 Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2012 - 2022 (USD Million)
    • 5.1.2 Global Non-Invasive Prenatal Testing Market Volume, by Geography, 2012 - 2022 (Number of Tests Performed)
  • 5.2 North America
    • 5.2.1 North America Non-Invasive Prenatal Testing Market Revenue, 2012 - 2022 (USD Million)
    • 5.2.2 North America Non-Invasive Prenatal Testing Market Volume, 2012 - 2022 (Number of Tests Performed)
  • 5.3 Europe
    • 5.3.1 Europe Non-Invasive Prenatal Testing Market Revenue, 2012 - 2022 (USD Million)
    • 5.3.2 Europe Non-Invasive Prenatal Testing Market Volume, 2012 - 2022 (Number of Tests Performed)
  • 5.4 Asia-Pacific
    • 5.4.1 Asia-Pacific Non-Invasive Prenatal Testing Market Revenue, 2012 - 2022 (USD Million)
    • 5.4.2 Asia-Pacific Non-Invasive Prenatal Testing Market Volume, 2012 - 2022 (Number of Tests Performed)
  • 5.5 Rest of the World (RoW)
    • 5.5.1 RoW Non-Invasive Prenatal Testing Market Revenue, 2012 - 2022 (USD Million)
    • 5.5.2 RoW Non-Invasive Prenatal Testing Market Volume, 2012 - 2022 (Number of Tests Performed)

Chapter 6 Recommendations

  • 6.1 Focus on improving technology in order to increase the accuracy, reduce the duration of result generation and price
  • 6.2 Focus on forming alliances with diagnostic service providers in Latin American and Asia-Pacific countries
  • 6.3 Mergers and acquisitions

Chapter 7 Company Profiles

  • 7.1 Ariosa Diagnostics, Inc.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Overview
    • 7.1.3 Product Portfolio
    • 7.1.4 Business Strategies
    • 7.1.5 Recent Developments
  • 7.2 Berry Genomics Co., Ltd.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Overview
    • 7.2.3 Product Portfolio
    • 7.2.4 Business Strategies
    • 7.2.5 Recent Developments
  • 7.3 BGI Diagnostics
    • 7.3.1 Company Overview
    • 7.3.2 Financial Overview
    • 7.3.3 Product Portfolio
    • 7.3.4 Business Strategies
    • 7.3.5 Recent Developments
  • 7.4 Illumina, Inc.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Overview
    • 7.4.3 Product Portfolio
    • 7.4.4 Business Strategies
    • 7.4.5 Recent Developments
  • 7.5 Laboratory Corporation of America Holdings (LabCorp)
    • 7.5.1 Company Overview
    • 7.5.2 Financial Overview
    • 7.5.3 Product Portfolio
    • 7.5.4 Business Strategies
    • 7.5.5 Recent Developments
  • 7.6 LifeCodexx AG
    • 7.6.1 Company Overview
    • 7.6.2 Financial Overview
    • 7.6.3 Product Portfolio
    • 7.6.4 Business Strategies
    • 7.6.5 Recent Developments
  • 7.7 Natera, Inc.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Overview
    • 7.7.3 Product Portfolio
    • 7.7.4 Business Strategies
    • 7.7.5 Recent Developments
  • 7.8 Sequenom, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Overview
    • 7.8.3 Product Portfolio
    • 7.8.4 Business Strategies
    • 7.8.5 Recent Developments

List of Figures

  • FIG. 1 Non-Invasive Prenatal Testing: Market Segmentation
  • FIG. 2 Global Non-Invasive Prenatal Testing Market, by Test, 2013 (USD Million)
  • FIG. 3 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2013 & 2022 (Value %)
  • FIG. 4 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Volume, by Geography, 2013 & 2022 (Volume %)
  • FIG. 5 Porter's Five Force Analysis: Global Non-Invasive Prenatal Testing Market
  • FIG. 6 Market Attractiveness Analysis: Global Non-Invasive Prenatal Testing Market, by Geography
  • FIG. 7 Non-Invasive Prenatal Testing: Market Share, by Key Players, 2013 (%)
  • FIG. 8 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2013 & 2022 (Value %)
  • FIG. 9 Comparative Analysis: Global Non-Invasive Prenatal Testing Market Volume, by Test, 2013 & 2022 (Volume %)
  • FIG. 10 Global BambniTest Test Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 11 Global BambniTest Test Market Volume, 2012 - 2022 (Number of Tests Performed)
  • FIG. 12 Global Harmony Test Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 13 Global Harmony Test Market Volume, 2012 - 2022 (Number of Tests Performed)
  • FIG. 14 Global informaSeq Test Market Revenue, 2014 - 2022 (USD Million)
  • FIG. 15 Global informaSeq Test Market Volume, 2014 - 2022 (Number of Tests Performed)
  • FIG. 16 Global MaterniT21 PLUS Test Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 17 Global MaterniT21 PLUS Test Market Volume, 2012 - 2022 (Number of Tests Performed)
  • FIG. 18 Global NIFTY Test Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 19 Global NIFTY Test Market Volume, 2012 - 2022 (Number of Tests Performed)
  • FIG. 20 Global Panorama Test Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 21 Global Panorama Test Market Volume, 2012 - 2022 (Number of Tests Performed)
  • FIG. 22 Global PrenaTest Test Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 23 Global PrenaTest Test Market Volume, 2012 - 2022 (Number of Tests Performed)
  • FIG. 24 Global verifi Test Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 25 Global verifi Test Market Volume, 2012 - 2022 (Number of Tests Performed)
  • FIG. 26 Global VisibiliT Test Market Revenue, 2014 - 2022 (USD Million)
  • FIG. 27 Global VisibiliT Test Market Volume, 2014 - 2022 (Number of Tests Performed)
  • FIG. 28 Global Other Tests Market Revenue, 2014 - 2022 (USD Million)
  • FIG. 29 Global Other Tests Market Volume, 2014 - 2022 (Number of Tests Performed)
  • FIG. 30 North America Non-Invasive Prenatal Testing Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 31 North America Non-Invasive Prenatal Testing Market Volume, 2012 - 2022 (Number of Tests Performed)
  • FIG. 32 Europe Non-Invasive Prenatal Testing Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 33 Europe Non-Invasive Prenatal Testing Market Volume, 2012 - 2022 (Number of Tests Performed)
  • FIG. 34 Asia-Pacific Non-Invasive Prenatal Testing Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 35 Asia-Pacific Non-Invasive Prenatal Testing Market Volume, 2012 - 2022 (Number of Tests Performed)
  • FIG. 36 RoW Non-Invasive Prenatal Testing Market Revenue, 2012 - 2022 (USD Million)
  • FIG. 37 RoW Non-Invasive Prenatal Testing Market Volume, 2012 - 2022 (Number of Tests Performed)
  • FIG. 38 LabCorp: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 39 Sequenom, Inc.: Annual Revenue, by Segment, 2011 - 2013 (USD Million)

List of Tables

  • TABLE 1 Market Snapshot: Global Non-Invasive Prenatal Testing (NIPT) Market (2013 & 2022)
  • TABLE 2 Global Non-Invasive Prenatal Testing Market Revenue, by Test, 2012 - 2022 (USD Million)
  • TABLE 3 Global Non-Invasive Prenatal Testing Market Volume, by Test, 2012 - 2022 (Number of Tests Performed)
  • TABLE 4 Global Non-Invasive Prenatal Testing Market Revenue, by Geography, 2012 - 2022 (USD Million)
  • TABLE 5 Global Non-Invasive Prenatal Testing Market Volume, by Geography, 2012 - 2022 (Number of Tests Performed)
  • TABLE 6 Ariosa Diagnostics, Inc.: Expenses & Revenue, 2011 - 2013 (USD Thousand)
  • TABLE 7 Sequenom, Inc.: Expenses & Revenue, 2011 - 2013 (USD Million)
Back to Top